Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2019 07:03 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss the Results of the Makena PROLONG Trial

WALTHAM, Mass., Oct. 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that NASDAQ has halted trading of the company’s common stock. The U.S. Food and Drug...
October 25, 2019 10:19 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces the Publication of the PROLONG Trial Evaluating 17-OHPC in the American Journal of Perinatology

WALTHAM, Mass., Oct. 25, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the results of PROLONG (Progestin’s Role in Optimizing Neonatal Gestation) were...
October 24, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Friday, November 1, 2019 at 8:00 a.m. ET

WALTHAM, Mass., Oct. 24, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its third quarter 2019 financial results will be released on Friday, November 1, 2019...
October 11, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesi™ (Bremelanotide Injection) Data in Obstetrics & Gynecology

WALTHAM, Mass., Oct. 11, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced that the data from its two pivotal, double-blind placebo-controlled Phase 3 trials (RECONNECT)...
October 08, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP

WALTHAM, Mass., Oct. 08, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) (“AMAG”) today announced that it has entered into a settlement agreement with Caligan Partners LP...
September 25, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference

WALTHAM, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will participate in the Cantor Fitzgerald Global Healthcare Conference in New York on Thursday, October 3,...
September 23, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Files Definitive Consent Revocation Statement and Sends Letter to Shareholders

Details Caligan Partners’ Reckless Business Ideas and Inexperienced Director Nominees Urges Shareholders to Sign and Return AMAG’s GREEN Consent Revocation Card WALTHAM, Mass., Sept. 23, 2019 ...
September 12, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Sends Letter to Shareholders

WALTHAM, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) (“AMAG” or the “Company”) today issued the following letter, which will be mailed to its shareholders. ...
September 05, 2019 08:41 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

WALTHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2019. Bill...
September 04, 2019 17:56 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Urges Stockholders to Take No Action on Caligan Partners’ Consent Solicitation Materials

WALTHAM, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) (“AMAG” or the “Company”) today responded to the preliminary consent solicitation filed by Caligan...